title: Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis.
abstract: BACKGROUND
  To evaluate diagnosis, management and outcome of breast cancer (BC) occurring after irradiation for Hodgkin's lymphoma (HL).
  
  
  METHODS
  39 cases of BC in 28 HL survivors were retrospectively reviewed. 21 patients were included in a case-control analysis.
  
  
  RESULTS
  The median age at diagnosis of HL and BC was 25.3 and 45.3 years, respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%) had bilateral disease. Mode of detection of the index breast cancers was by mammographic screening in 17 patients (60.7%), palpable lump in 8 patients (28.6%), clinical examination in two patients (7.1%), and unknown in one patient (3.6%). Case-control analysis showed that histological features and prognosis of BC after HL were similar to those of primary BC, however, for BC after HL, mastectomy was the predominant surgery (P = .001) and adjuvant radiotherapy and anthracycline-based chemotherapy were less frequently used as compared to primary BC (P < .001 and .003, respectively).
  
  
  CONCLUSIONS
  The previous history of HL does not appear to be a poor prognostic factor for BC occurring thereafter.
authors: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. almeldin@gmail.com
authors: Mohamed A
authors: MA
authors: Alm El-Din
authors: Kevin S
authors: KS
authors: Hughes
authors: Rita A
authors: RA
authors: Raad
authors: Saveli I
authors: SI
authors: Goldberg
authors: Alan C
authors: AC
authors: Aisenberg
authors: Andrzej
authors: A
authors: Niemierko
authors: Alphonse G
authors: AG
authors: Taghian
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000209:etiology*; D016022:Case-Control Studies; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000209:etiology*; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome; D055815:Young Adult